Charles Hugh-Jones

Director Técnico/Científico/I+D en FRESENIUS MEDICAL CARE AG .

56 años

Health Technology

Health Services

Perfil

Charles Hugh-Jones is the Global Chief Medical Officer at Fresenius Medical Care AG, starting in 2026.
Formerly, Dr. Hugh-Jones was Chief Executive Officer at Volastra Therapeutics, Inc., Chief Medical Officer at Allergan UC from 2018 to 2020, and worked at Addleshaw Booth & Co. from 2004 to 2007.

Cargos activos de Charles Hugh-Jones

Empresas	Cargo	Inicio
FRESENIUS MEDICAL CARE AG	Director Técnico/Científico/I+D	01/01/2026

Todos los cargos activos de Charles Hugh-Jones

Antiguos cargos conocidos de Charles Hugh-Jones.

Empresas	Cargo	Fin
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Director Ejecutivo	27/05/2025
ALLERGAN PLC	Director Técnico/Científico/I+D	08/05/2020

Ver el detalle de la experiencia de Charles Hugh-Jones.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Charles Hugh-Jones.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Fresenius Medical Care AG Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products	Health Services
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products	Health Technology
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Health Technology